Connect Biopharma Holdings (CNTB) Receivables - Other (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Receivables - Other of $32000.0 for Q1 2026, down 78.38% sequentially from $148000.0 in Q4 2025, and down 80.84% YoY from $167000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Receivables - Other (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Receivables - Other for 7 years, with the latest figure at $32000.0 in Q1 2026.
- Quarterly Receivables - Other fell 80.84% year-over-year to $32000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32000.0 (down 80.84% YoY) and the FY2025 annual result came in at $148000.0, down 43.51% from the prior year.
- Receivables - Other declined to $32000.0 in Q1 2026 per CNTB's latest filing, from $148000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $7.1 million in Q2 2022 and troughed at $32000.0 in Q1 2026.
- A 5-year average of $1.7 million and a median of $262000.0 in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other declined 7.3% in 2023, then slumped 95.66% in 2024.
- Over 5 years, Receivables - Other stood at $3.3 million in 2022, then plunged by 89.34% to $351000.0 in 2023, then decreased by 25.36% to $262000.0 in 2024, then tumbled by 43.51% to $148000.0 in 2025, then sank by 78.38% to $32000.0 in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $32000.0, $148000.0, and $157000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Connect Biopharma Holdings | 144.95 Mn | 144.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Mar 31, 2026 | 32,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Sep 30, 2025 | 157,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Jun 30, 2025 | 193,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Dec 31, 2024 | 262,000.00 |
| Jun 30, 2024 | 287,000.00 |
| Jun 30, 2024 | 287,000.00 |
| Dec 31, 2023 | 351,000.00 |
| Dec 31, 2023 | 351,000.00 |
| Jun 30, 2023 | 6.61 Mn |
| Jun 30, 2023 | 6.61 Mn |